Heart failure is a major, cause of death worldwide, most frequently
secondary toacardiomyopathicdisorder. The rolesofviruses, immunity,
cytokines and genetics as sources of heart failure have been
relatively understated in the rapidly developing world of clinical
cardiology. Yet, great progress in molecular biology and the recent
application of new techniquesto
studiesoftheetiologyandpathogenesisofcardiomyopathies and heart
failure has shed new light in an area ready to undergo major
developmentsandadvances. This book is an effort to present an
up-to-date account of eXIstmg
knowledge,includingrecentdevelopmentsinthisfield. Chapterscovering
severaldisciplinesincludingbiochemistry,immunology,molecularbiology,
virology,epidemiologyandclinicalmedicinehavebeenincluded,offeringa
"bench-to-bedside"and"bedside-to-bench"criticalreviewofeveryaspects
of heart failure and cardiomyopathies, by world renowned, expert
researchers and clinicians. These opinion leaders review all
significant advances in our understandingofheart failure and
cardiomyopathies, and describe theimprovements indiagnosis and
treatment that areexpectedto optimize the overall management of
patients. The identification of
establishedornewlyrecognizedmolecules,cytokines,viruses,andgenes,as
well as an understandingofthe mechanisms by which these factors may
cause cardiomyopathic disorders and induce heart failure depends on
a
multidisciplinaryapproachwhichthisbookattemptstouniquelyencompass.
Therefore,wehopethatitwillbeanimportantresource,notonlyforclinical
cardiologists,butalso
forgeneralpractitioners,pediatriciansandspecialists in infectious
diseases, as well as trainees and graduates in biochemistry,
immunology, genetics, molecular biology, virology, pharmacology,
and epidemiology. AkiraMatsumori,MD,PhD Ie INTRODUCTORYCHAPTER
CARDIOMYOPATHIESANDHEARTFAILURE
Biomolecular,InfectiousandImmuneMechanisms AkiraMatsumori,MD,PhD
DepartmentofCardiovascularMedicine
KyotoUniversityGraduateSchoolofMedicine Kyoto,Japan 1 SUMMARY
Theclinicalpresentationofviralmyocarditisisvariable. Whenmyocardial
necrosis is diffuse, congestive heart failure develops, and later,
dilated cardiomyopathy. If the myocardial lesions are localized, a
ventricular aneurysmforms.
Whencomplicatedbyarrhythmias,myocarditispresentsas arrhythmogenic
right ventricular cardiomyopathy. When myocardial
necrosisislocalizedtothesubendocardialregion,restrictivecardiomyopathy
may develop. While it has not been established that hypertrophic
cardiomyopathy maybeacomplicationofviral myocarditis, asymmetrical
septal hypertrophy has, in fact, sometimesbeen observed in patients
with myocarditis.
TheimportanceofhepatitisCvirusinfectionhasrecentlybeen
notedinpatientswithmyocarditis,dilatedandhypertrophiccardiomyopathy.
General
Imprint: |
Springer-Verlag New York
|
Country of origin: |
United States |
Series: |
Developments in Cardiovascular Medicine, 248 |
Release date: |
July 2003 |
First published: |
2003 |
Editors: |
Akira Matsumori
|
Dimensions: |
235 x 155 x 35mm (L x W x T) |
Format: |
Hardcover
|
Pages: |
531 |
Edition: |
2003 ed. |
ISBN-13: |
978-1-4020-7438-7 |
Categories: |
Books >
Medicine >
Clinical & internal medicine >
Cardiovascular medicine
|
LSN: |
1-4020-7438-7 |
Barcode: |
9781402074387 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!